acut
respiratori
diseas
ard
account
larg
proport
acut
morbid
well
mortal
worldwid
among
acut
viral
respiratori
tract
infect
lead
caus
appropri
major
viral
pathogen
includ
influenza
viru
respiratori
syncyti
viru
rsv
coronaviru
adenoviru
rhinoviru
children
age
five
combin
global
mortal
influenza
rsv
reach
death
year
respiratori
virus
adenoviru
rhinoviru
associ
lower
mortal
signific
morbid
caus
huge
econom
burden
highli
pathogen
emerg
reemerg
coronavirus
may
caus
epidem
pandem
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
pose
great
threat
global
public
health
recent
novel
coronaviru
http
wwwwhoint
caus
pneumonia
confirm
case
patient
includ
seriou
condit
dead
recov
http
full
genom
sequenc
coronaviru
releas
januari
http
fromgroupmessag
ident
bat
coronaviru
accur
fast
diagnosi
caus
viral
pathogen
import
select
appropri
treatment
save
peopl
live
stop
epidem
reduc
unnecessari
use
antibiot
virus
mention
caus
upper
lower
respiratori
tract
infect
well
overlap
clinic
present
make
difficult
physician
distinguish
caus
agent
without
solid
laboratori
analysi
convent
diagnost
method
viral
cultur
directindirect
immunofluoresc
assay
ifa
labor
intens
limit
sensit
rapid
accur
diagnosi
respiratori
virus
help
epidemiolog
monitor
along
take
effect
prevent
step
implement
appropri
antivir
therapi
past
decad
evolut
viral
diagnost
test
seen
way
convent
approach
rapid
antigen
detect
recent
highli
sensit
nucleic
acid
amplif
test
naat
test
poct
develop
review
describ
variou
approach
current
avail
develop
diagnosi
common
respiratori
viru
infect
human
anticip
data
assist
clinic
laboratori
rapidli
accur
diagnos
respiratori
virus
thu
provid
physician
essenti
inform
time
appropri
treatment
patient
commonli
use
diagnost
approach
influenza
viru
rsv
coronaviru
adenoviru
rhinoviru
summar
tabl
describ
detail
follow
review
viral
cultur
gold
standard
diagnos
influenza
viral
infect
approach
includ
inocul
correspond
cell
line
madin
darbi
canin
kidney
mdck
rhesu
monkey
kidney
llc
clinic
sampl
propag
seven
day
monitor
develop
cytopath
effect
cpe
final
confirm
influenza
viru
infect
hemadsorpt
use
erythrocyt
specif
antibodi
stain
immunofluoresc
microscopi
ifa
use
sinc
directli
stain
respiratori
epitheli
cell
deriv
nasopharyng
aspir
swab
fluoresc
label
influenza
antibodi
current
sever
immunosorb
elisa
test
avail
diagnosi
influenza
viru
infect
howev
test
often
show
lower
sensit
compar
nucleic
method
novel
immunoassay
base
europium
nanoparticl
develop
rapidli
detect
strain
influenza
strain
influenza
b
virus
high
sensit
specif
convent
diagnost
method
gener
lower
sensit
specif
rel
molecular
method
develop
laboratori
approach
viru
diagnosi
isol
viral
pathogen
secret
sampl
becom
much
easier
rapid
influenza
diagnost
test
ridt
offer
faster
approach
detect
influenza
b
virus
howev
limit
abil
identifi
subtyp
influenza
virus
addit
test
perform
ie
sensit
specif
vari
wide
exampl
novemb
suspect
influenza
patient
analyz
use
direct
antigen
ez
flu
ab
kit
sensit
specif
ridt
respect
naat
assay
base
polymeras
chain
reaction
pcr
detect
genet
materi
rather
viral
antigen
antibodi
therefor
optim
extract
viral
genet
materi
requir
one
advantag
naat
ridt
naat
abl
identifi
differ
subtyp
influenza
virus
trombetta
group
found
naat
show
much
higher
sensit
influenza
influenza
b
virus
despit
rel
lower
specif
varieti
naat
assay
revers
isotherm
assay
lamp
test
appear
diagnosi
influenza
viral
infect
human
use
lamp
approach
poon
group
demonstr
sensit
detect
season
influenza
virus
clinic
specimen
analyt
sensit
copi
per
reaction
compar
assay
revers
transcript
assay
show
sensit
specif
detect
pandem
viru
assay
also
use
detect
highli
pathogen
avian
influenza
virus
compar
higher
sensit
approach
howev
high
cost
naat
complex
equip
requir
need
train
profession
make
naat
assay
less
practic
area
limit
resourc
addit
approach
approach
develop
detect
influenza
virus
offer
novel
tool
accur
rapid
diagnosi
influenza
epidem
pandem
assay
use
multipl
oligonucleotid
special
design
target
conserv
sequenc
encod
ha
na
protein
influenza
b
virus
instanc
zhao
research
group
develop
gold
genom
microarray
assay
abl
differenti
virus
major
season
influenza
virus
explain
oligonucleotid
design
basi
consensu
sequenc
ha
na
gene
viru
gene
virus
group
expand
platform
design
specif
oligonucleotid
ha
na
gene
pandem
viru
enabl
detect
pandem
viru
distinguish
influenza
virus
particularli
combin
diagnost
platform
report
use
nanomicroarray
screen
multiplex
sequenc
ng
assay
confirm
simultan
identifi
character
influenza
b
virus
singl
sampl
recent
whole
genom
sequenc
wg
method
minion
portabl
sequenc
develop
test
influenza
b
virus
subsequ
valid
illumina
miseq
platform
overal
accuraci
precis
well
recal
rate
respect
read
respect
read
elisa
immunofluoresc
assay
tradit
assay
identifi
rsv
howev
modifi
elisa
method
develop
target
rsv
f
protein
detect
rsv
within
minut
low
cost
immunofluoresc
assay
rapidli
detect
rsv
antigen
use
primari
secondari
antibodi
exampl
direct
fluoresc
antibodi
assay
dfa
requir
certain
number
cell
specimen
sensit
specif
respect
wide
use
detect
rsv
clinic
laboratori
simplic
rapid
reason
assay
particular
use
countri
sinc
potenti
elimin
prolong
hospit
unnecessari
use
antibiot
semiconductor
quantum
dot
use
biolog
biomed
applic
uniqu
optic
electron
featur
assay
detect
rsv
f
protein
use
thioglycol
tga
cadmium
tellurid
cdte
particl
bioconjug
rsv
protein
mab
overcom
dfa
disadvantag
rel
low
sensit
background
stain
rapid
fade
dye
also
assay
sensit
probe
f
g
protein
qd
confoc
microscopi
could
detect
progress
rsv
infect
cell
line
method
found
sensit
compar
later
flow
immunoassay
lfia
anoth
rapid
rsv
detect
method
base
immunochromatograph
techniqu
use
sampl
nasal
wash
aspir
mani
lfia
kit
avail
market
bd
directigen
ez
rsv
binax
rsv
rsv
remel
xpect
quicklab
rsv
test
sensit
specif
abovement
kit
normal
higher
differ
manufactur
pcr
method
base
nest
techniqu
involv
outer
inner
primer
design
f
gene
method
develop
circl
time
oper
adult
infect
therefor
use
detect
sampl
low
viral
titer
sensit
perform
identif
use
detect
approach
follow
novel
pcr
detect
method
establish
modif
convent
pcr
approach
exampl
quantit
pcr
rapid
specif
sensit
taqman
pcr
method
detect
subgroup
quantit
pathogen
assay
increas
sensit
convent
pcr
need
two
set
pair
come
nucleotid
sequenc
nucleocapsid
n
gene
fusion
f
gene
target
respect
quantit
taqman
pcr
assay
use
detect
nasopharyng
aspir
obtain
children
respiratori
symptom
hong
kong
detect
sampl
includ
contrast
cell
assay
identifi
immunofluoresc
assay
identifi
specimen
among
identifi
taqman
pcr
assay
suggest
greater
accuraci
sensit
taqman
pcr
assay
addit
lock
nucleic
acid
lna
nest
otnrt
assay
high
sensit
low
incid
detect
rsv
total
nasopharyng
aspir
sampl
test
confirm
sequenc
product
indic
sensit
detect
rsv
clinic
sampl
moreov
rapid
amplif
assay
develop
diagnost
method
detect
subgroup
rsv
b
genom
clinic
specimen
method
mainli
util
enzym
mixtur
includ
dna
bind
protein
ssb
recombinas
uvsx
dna
polymeras
detect
rna
amplicon
rsv
perform
less
minut
high
specif
furthermor
revers
transcript
strand
amplif
revers
transcript
isotherm
nucleic
acid
amplif
rapid
detect
rsv
good
sensit
sinc
detect
copi
rsv
rna
within
minut
need
highli
purifi
rna
detect
rsv
reduc
complex
specimen
prepar
shorten
total
detect
cycl
clinic
specimen
coronavirus
belong
famili
coronavirida
bat
recogn
natur
reservoir
vector
varieti
coronavirus
virus
cross
speci
barrier
infect
human
mani
differ
kind
anim
includ
avian
rodent
chiropt
coronaviru
may
caus
respiratori
neurolog
diseas
far
six
human
coronavirus
hcov
identifi
includ
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
human
coronaviru
first
report
june
caus
human
respiratori
diseas
classifi
lineag
c
structur
compris
kb
rna
genom
close
relat
lineag
c
tylonycteri
bat
cov
pipistrellu
bat
cov
genom
analysi
lineag
c
human
shown
high
similar
deriv
camel
nucleotid
ident
suggest
human
camel
isol
belong
coronaviru
speci
septemb
case
infect
includ
death
countri
report
http
wwwwhointemergenciesmerscoven
commerci
vaccin
therapeut
treatment
current
avail
mer
rapid
accur
diagnosi
import
prevent
transmiss
outbreak
current
diagnost
test
coronaviru
includ
revers
transcript
pcr
revers
transcript
isotherm
amplif
well
duplex
method
develop
base
primer
probe
target
conserv
spike
gene
use
templat
templat
respect
adequ
detect
limit
copiesml
achiev
singleplex
assay
design
detect
envelop
gene
upe
open
read
frame
gene
separ
compar
refer
singleplex
assay
sensit
singleplex
upe
assay
respect
six
commerci
avail
rna
detect
kit
base
avail
includ
accupow
bioneer
korea
anyplex
seegen
korea
diaplexq
solgent
korea
lightmix
roch
molecular
diagnost
switzerland
ultrafast
kit
nanobiosi
korea
powerchek
kogen
biotech
korea
powerchek
mer
pcr
anyplex
ii
upe
detect
diaplexq
mer
viru
detect
kit
consist
two
step
singl
gene
target
upstream
region
upe
region
screen
multipl
gene
target
upe
region
final
confirm
accupow
real
time
lightmix
molecular
dx
ultrafast
labchip
merscov
pcr
kit
use
two
singl
reagent
detect
upe
gene
simultan
report
respiratori
virus
base
valid
test
includ
specif
panel
clinic
specimen
sensit
specif
kit
detect
upe
reach
confid
interv
ci
ci
respect
base
result
high
inhibit
panel
accupow
powerchek
lowest
sensit
presenc
pcr
inhibit
therefor
overal
sensit
specif
six
kit
suffici
diagnos
infect
assay
two
primer
set
construct
one
set
target
n
gene
one
set
target
gene
set
shown
high
effici
amplifi
target
sequenc
deriv
differ
strain
observ
respiratori
virus
huang
research
group
establish
nucleic
acid
visual
techniqu
combin
techniqu
vertic
flow
visual
strip
detect
n
gene
assay
detect
synthes
rna
transcript
rna
without
multipl
includ
thu
exhibit
high
specif
mention
assay
rapid
accur
detect
infect
bonhan
kooa
team
design
sensor
capabl
rapid
pathogen
identif
use
direct
amplif
clinic
sampl
method
detect
varieti
virus
includ
high
sensit
specif
abl
distinguish
hcov
clinic
sampl
within
minut
taqman
assay
provid
rapid
sensit
intern
diagnost
detect
detect
upe
open
read
frame
orf
method
reliabl
specif
reproduc
addit
differ
tradit
sampl
detect
method
method
combin
two
step
one
step
thu
increas
sensit
measur
exampl
copi
rna
templat
per
reaction
upe
respect
rapid
np
detect
method
use
preliminari
rapid
screen
infect
due
high
specif
moder
sensit
detect
limit
assay
sensit
lower
antigen
captur
elisa
isol
adenoviru
growth
cell
cultur
immunolog
detect
gener
thought
gold
standard
sampl
throat
swab
stool
specimen
collect
patient
treat
overnight
antibiot
centrifug
supernat
inocul
suscept
cell
graham
cpe
observ
cell
incub
hadv
isol
serotyp
hadv
determin
detect
antigen
determin
penton
protein
hemagglutin
inhibit
hi
test
hadv
also
type
detect
antigen
determin
hexon
protein
neutral
test
nt
howev
method
requir
experienc
technician
analyz
result
result
still
uncertain
differ
type
hadv
infect
caus
differ
diseas
differ
symptom
thu
detect
antigen
antibodi
make
diagnosi
hadv
rapid
sensit
indirect
elisa
detect
iga
igm
igg
antibodi
hadv
human
serum
plasma
immunofluor
latex
agglutin
test
lat
enzym
immunoassay
eia
also
common
diagnost
method
accept
clinic
laboratori
simpl
rapid
characterist
emerg
detect
method
gradual
replac
tradit
detect
technolog
mani
laboratori
clinic
practic
provid
reliabl
new
method
diagnosi
hadv
specif
antigen
determin
hexon
surfac
hadv
identifi
neutral
antibodi
antigen
determin
hexon
protein
two
loop
divid
seven
hypervari
region
hvr
among
hvr
becom
newest
method
choic
adenoviru
type
madisch
develop
diagnost
method
classifi
serotyp
amplif
sequenc
amplif
element
shimada
studi
conserv
hexon
gene
hvr
type
serotyp
limit
hadv
serotyp
lead
corneal
conjunct
pcr
sensit
quantit
techniqu
diagnos
hadv
infect
pcr
consensu
primer
probe
conserv
region
hexon
gene
design
detect
prototyp
sensit
assay
copi
per
run
linear
rang
quantit
copiesrun
realstar
adenoviru
pcr
kit
diagnost
test
vitro
detect
quantif
dna
sensit
human
viral
pathogen
compar
realstar
adenoviru
pcr
kit
qpcr
assay
sensit
reliabl
detect
quantif
dna
perform
characterist
qpcr
evalu
realstar
adenoviru
pcr
kit
use
clinic
specimen
profici
sampl
studi
hadv
qpcr
assay
detect
six
hadv
speci
f
except
speci
g
use
realstar
adenoviru
pcr
kit
refer
sensit
specif
respect
qpcr
assay
correl
two
assay
quit
good
furthermor
qpcr
assay
linear
rang
copiesm
cv
valu
suggest
quit
low
variat
rhinovirus
rv
rna
virus
belong
famili
picornavirida
genu
enteroviru
classifi
speci
c
serotyp
rv
small
rna
virus
icosahedr
symmetr
capsid
rv
frequent
caus
respiratori
tract
infect
children
adult
common
rv
speci
caus
lower
airway
ill
wheez
acut
asthma
lead
sever
symptom
children
cultur
isol
viru
combin
acid
stabil
test
classic
method
rv
diagnosi
howev
assay
labori
limit
valu
clinic
treatment
human
rv
antibodi
detect
immunolog
method
complement
fixat
test
cft
hi
test
elisa
howev
owe
lack
suitabl
antigen
cover
larg
number
rv
serotyp
applic
method
greatli
limit
contrast
pcr
assay
detect
rv
use
sequenc
detect
system
assay
improv
workflow
reduc
prepar
time
elimin
might
introduc
cdna
transfer
revers
transcript
reaction
pcr
reaction
step
assay
base
extrem
sensit
pcr
detect
airborn
rv
limit
detect
lod
approxim
median
tissu
cultur
infecti
dose
assay
develop
valid
use
intern
extract
control
serial
dilut
rhinoviru
rna
refer
standard
lod
limit
quantif
loq
assay
log
copiesml
log
copiesml
respect
linear
conserv
log
copiesml
reproduc
r
rapid
develop
wg
technolog
laboratori
may
perform
wg
human
rv
isol
clinic
discoveri
data
volum
hrv
sequenc
increas
improv
significantli
help
research
clinician
understand
evolutionari
recombin
rv
may
improv
diagnosi
although
singl
respiratori
virus
detect
patient
symptom
respiratori
virus
may
also
exist
simultan
children
especi
year
age
present
higher
frequenc
coinfect
multiplex
assay
contain
one
viral
gene
target
singl
tube
advantag
rapid
detect
sever
potenti
viral
pathogen
simultan
multiplex
pcr
allow
simultan
detect
multipl
respiratori
virus
short
time
compar
singleplex
approach
multiplex
diagnost
approach
higher
sampl
throughput
sampl
per
run
shorter
turnaround
time
hour
smaller
amount
sampl
requir
luminex
nxtag
respiratori
pathogen
panel
new
multiplex
pcr
system
upgrad
xtag
respiratori
viral
panel
assay
assay
demonstr
good
diagnost
perform
detect
multiplex
respiratori
pathogen
total
clinic
respiratori
specimen
includ
hadv
rv
influenza
viral
cultur
sampl
test
overal
diagnost
sensit
ci
specif
ci
assay
demonstr
sensit
detect
hadv
number
assay
develop
describ
summar
tabl
recent
feng
group
design
lock
nucleic
acid
primer
develop
multiplex
nest
assay
could
detect
rsv
hrv
human
metapneumoviru
hmpv
simultan
higher
sensit
lower
cost
compar
individu
assay
evalu
use
clinic
sampl
sensit
rsv
hrv
hmpv
copi
per
reaction
observ
among
common
respiratori
virus
total
detect
time
assay
hour
sampl
panther
fusion
respiratori
assay
develop
detect
multipl
respiratori
virus
consist
three
multiplex
pcr
panel
flu
abrsv
paraflu
parainfluenza
hadvhmpvrv
perform
characterist
assay
detect
flu
ab
rsv
paraflu
hmpv
rv
hadv
evalu
use
nasopharyng
np
lower
respiratori
tract
lrt
sampl
score
method
use
calcul
ci
posit
percent
agreement
ppa
neg
percent
agreement
npa
np
sampl
panther
fusion
assay
ppa
npa
target
lrt
sampl
ppa
target
npa
target
except
hmpv
fast
track
diagnost
respiratori
pathogen
kit
commerci
multiplex
nucleic
acid
amplif
assay
kit
evalu
use
sampl
patient
ill
kit
sensit
specif
compar
realstar
kit
addit
upon
modif
kit
sensit
increas
multiplex
assay
gexp
assay
develop
detect
differ
respiratori
virus
simultan
seventeen
set
chimer
primer
design
initi
anoth
pair
univers
primer
use
subsequ
cycl
gexp
assay
achiev
sensit
copi
singl
viru
premix
viral
target
present
sensit
copi
suggest
assay
sensit
specif
method
detect
respiratori
virus
qiagen
resplex
ii
kit
use
multiplex
amplif
combin
suspens
array
detect
detect
total
respiratori
virus
includ
flu
ab
piv
rsv
hmpv
rhinovirus
rv
enteroviru
ev
human
bocaviru
hbov
hadv
four
coronavirus
flua
nasopharyng
swab
specimen
specif
test
sensit
hmpv
bov
report
respect
sensit
flua
env
rsv
rel
low
filmarray
multiplex
pcr
system
multiplex
pcr
panel
use
detect
virus
includ
bacteria
platform
requir
minut
time
sampl
prepar
hour
devic
run
time
test
platform
integr
cell
lysi
reagent
dnarna
extract
reagent
purif
reagent
amplif
reagent
also
detect
reagent
one
pouch
finish
run
softwar
analys
perform
test
result
present
integr
tabl
includ
test
pathogen
studi
reveal
sensit
specif
compar
combin
refer
esensor
xtag
test
sensit
specif
compar
prodess
assay
respiratori
virus
major
caus
symptomat
respiratori
tract
infect
age
group
worldwid
time
accur
diagnosi
virus
enabl
appropri
treatment
infect
tradit
modern
molecular
diagnost
approach
advantag
disadvantag
principl
summar
sever
common
respiratori
virus
influenza
viru
human
rsv
coronaviru
hadv
rhinoviru
discuss
review
howev
respiratori
virus
prone
antigen
drift
caus
point
mutat
viral
gene
new
strain
pandem
potenti
may
result
gene
reassort
continu
pose
new
challeng
rapid
accur
detect
respiratori
viru
infect
human
therefor
identif
mutat
within
viral
genom
quit
essenti
howev
effort
pinpoint
genet
mutat
human
respiratori
virus
reli
sequenc
singl
gene
gene
famili
use
sanger
sequenc
although
approach
fruit
cost
throughput
sanger
sequenc
gener
prohibit
systemat
sequenc
gene
make
exom
recent
develop
ng
technolog
chang
paradigm
provid
capabl
rapidli
sequenc
exom
transcriptom
genom
rel
low
cost
applic
ng
diagnosi
identif
respiratori
pathogen
especi
patient
sever
pneumonia
unknown
origin
infect
becom
popular
ng
exhibit
abil
detect
coinfect
sever
pneumonia
patient
perform
well
diagnos
sever
pneumonia
compar
convent
method
infrequ
circul
genotyp
genom
character
whole
genom
viral
strain
promot
studi
epidemiolog
pathogen
aid
diagnosi
new
emerg
respiratori
viru
wg
enabl
better
identif
transmiss
event
outbreak
alway
possibl
sequenc
author
declar
conflict
interest
nz
lw
xd
rl
ms
ch
ys
lh
draft
manuscript
fy
ld
sj
revis
edit
manuscript
author
read
made
final
approv
manuscript
